Sotrovimab in solid organ transplant recipients with COVID-19: a systematic review and meta-analysis
Description
CONCLUSIONS: These results suggest that sotrovimab may improve efficacy outcomes among SOTRs with COVID-19. Nevertheless, additional high-quality trials are necessary to confirm these findings.
